ReWalk 7
[commercial]exoskeleton · exoskeletons · 1 deployments in catalog
Manufacturer
LifewardForm Factor
exoskeleton
Lifecycle
commercial
Operational Reality
Audited
Deployments
1
Target Price
Custom Quote
- EXOSKELETON
- COMMERCIAL
Description
Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.
Key facts & specs
- website
- https://ir.golifeward.com/news-releases/news-release-details/fda-issues-clearance-rewalk-7-exoskeleton
- maturity
- commercial
- lifecycle
- active
- form factor
- exoskeleton
- manufacturer
- Lifeward
- deployments count
- 1
- Maturity stage
- commercial
- Use
- medical (personal, SCI)
- Control
- weight-shift triggered powered gait
- Powered
- yes (motor-driven)
- Regulatory
- FDA cleared 2025-03
- Body region
- lower-limb
- Availability
- commercial (2025 launch)
- Type
- Exoskeleton for rehabilitation
Safety record
1 recall and 1 incident on record (2 serious). Most recent: Dec 2019.
FAQ
What is ReWalk 7?
Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.
Is ReWalk 7 actually deployed in the real world?
Yes. ReWalk 7 is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes ReWalk 7?
ReWalk 7 is made by Lifeward, based in Marlborough, MA, USA / Yokneam Ilit, Israel, founded in 2001.
Where is ReWalk 7 deployed?
1 verified deployment of ReWalk 7 is on the DEPLOY registry, including at United States.
Can you buy ReWalk 7?
ReWalk 7 is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
Is ReWalk 7 FDA cleared?
ReWalk 7 has 2 regulatory records on the DEPLOY registry: CE marking, cleared; FDA 510(k) clearance (K241822), cleared. See the Regulatory filings section for each agency source.
What are alternatives to ReWalk 7?
On the DEPLOY registry, comparable exoskeleton robots to ReWalk 7 include Ant-H1 Pro, Cyberdyne HAL, German Bionic Cray X, HANK.
How does ReWalk 7 compare to Ant-H1 Pro?
ReWalk 7 and Ant-H1 Pro (Kenqing Technology · 5 deployments) are both exoskeleton robots on the DEPLOY registry. ReWalk 7 has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is ReWalk 7 a top exoskeleton?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, ReWalk 7 ranks in roughly the top 81% of exoskeleton models tracked by the registry.
What is ReWalk 7's maturity stage?
ReWalk 7 is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is ReWalk 7 safe?
ReWalk 7 has 2 active incidents on record in the DEPLOY registry. 1 recall and 1 incident on record (2 serious). Most recent: Dec 2019. Retracted incidents are excluded from this count.
How much does a ReWalk exoskeleton cost?
The ReWalk Personal Exoskeleton costs approximately $77,000 to $85,000 per unit. It is a wearable robotic exoskeleton that provides powered leg motion for people with spinal cord injury to stand and walk. ReWalk 7 is the latest generation, FDA-cleared under 510(k) K241822.